What does science say about Magnesium and Primary biliary cholangitis?
- We don’t say yes or no. We show what has been studied.
- Working in a lab or in animals does not mean it works in people.
- Don’t stop or change your treatment without talking to your doctor.
What has been studied
- Lab studies (cells)Tests on cells in a dish.Source: PubMed · as of 9 Nov 2026 · Open the search at PubMed0studies
- Animal studiesTests in mice, rats or other animals.Source: PubMed · as of 9 Nov 2026 · Open the search at PubMed0studies
- Studies in peoplePublished studies with human participants.Source: PubMed · as of 9 Nov 2026 · Open the search at PubMed5studies
- Registered trials in peopleTrials entered in a public registry, whatever their result.ClinicalTrials.gov: 5 · as of 9 Nov 2026 · Open the search at ClinicalTrials.govEU CTIS: 0 · as of 9 Nov 2026 · Open the search at EU CTISBy phase:Phase 3 (3)Phase 2/3 (1)Phase 1 (1)By status:Recruiting (3)Completed (1)Running, not recruiting (1)Countries (16):United States (5)Argentina (2)Greece (2)Italy (2)Bulgaria (1)Czechia (1)Estonia (1)Spain (1)France (1)Croatia (1)Ireland (1)Iceland (1)Latvia (1)Netherlands (1)Poland (1)Slovakia (1)With a linked publication (results): 0 of 5The registries do not tell us here whether results were posted; a linked publication is shown instead.5trials
- Approved treatmentApproved by a medicines regulator for this disease.No
Examples of what we found
The trials
Phase 3
Study of Saroglitazar Magnesium for PBC Patients With Incomplete Response or Intolerant to UDCA Therapy
Recruiting · Czechia, Greece, Italy, United States
ClinicalTrials.gov · NCT07424677Phase 3
Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes
Recruiting · Bulgaria, Estonia, Spain, France, Greece, Croatia, Ireland, Italy, Latvia, Netherlands, Poland, Slovakia, United States
ClinicalTrials.gov · NCT07216235Phase 3
Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis
Running, not recruiting · Argentina, United States
ClinicalTrials.gov · NCT06427395Phase 2/3
Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis
Completed · Argentina, Iceland, United States
ClinicalTrials.gov · NCT05133336
Thinking of paying for it? Read this first
- Ask for published results. Stories, thank-you letters and "patients report" are not results. Ask where the results were published.
- Know what you pay for. Ask in writing: what exactly is included, who gets the money, and what happens if you stop.
- Ask your own doctor first. Some products interfere with chemotherapy, radiation or other medicines. Your treating doctor can check this.
- Do not stop standard treatment for it. Do not stop or delay your treatment without talking to your care team.
Other treatments people ask about
- StatinsStep: Large trials
- Vitamin DStep: Large trials
- Cannabis and cannabinoids (CBD, THC)Step: Reports in people
- Fasting and fasting-mimicking dietStep: Reports in people
- High-dose vitamin CStep: Reports in people
- MetforminStep: Reports in people
- Curcumin (turmeric)Step: Animal studies only
- MelatoninStep: Animal studies only
Not medical advice. Talk to the care team before changing treatment.